Epstein-Barr Virus in Pediatric Multiple Sclerosis

JAMA

Volumn 291, Issue 15, 2004, Pages 1875-1879

  Alotaibi, Suad ^a   Kennedy, Julia ^b   Tellier, Raymond ^b   Stephens, Derek ^b   Banwell, Brenda ^b,c  

^a AL SABAH HOSPITAL   (Kuwait)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; VIRUS ANTIGEN;

ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; EMERGENCY WARD; EPSTEIN BARR VIRUS; FEMALE; HERPES VIRUS SAIMIRI; HUMAN; INTERMETHOD COMPARISON; MALE; MULTIPLE SCLEROSIS; OUTCOMES RESEARCH; PARVOVIRUS; PATIENT SELECTION; PRIORITY JOURNAL; SEROLOGY; VARICELLA ZOSTER VIRUS; VIRUS CAPSID; VIRUS INFECTION;

EID: 1942478620     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.15.1875     Document Type: Article

References (24)

1. Ascherio A, Munch M. Epstein-Barr virus and multiple sclerosis. Epidemiology. 2000;11:220-224.
2. Bray PF, Culp KW, McFarlin DE, et al. Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection. Neurology. 1992;42:278-282.
3. Larsen PD, Bloomer LC, Bray PF. Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis. Neurology. 1985;35:435-438.
4. Bray PF, Bloomer LC, Salmon VC, Bagley MH, Larsen PD. Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis. Arch Neurol. 1983;40:406-408.
5. Ascherio A, Munger KL, Lennette ET, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA. 2001;286:3083-3088.
6. Evans AS, Niederman JC. Epstein-Barr virus. In: Evans AS, eds. Viral Infections of Humans, Epidemiology and Control. New York, NY: Plenum Publishing Corp; 1989:265-292.
7. Duquette P, Murray TJ, Pleines J, et al. Multiple sclerosis in childhood: clinical profile in 125 patients. J Pediatr. 1987;111:359-363.
8. Ghezzi A, Deplano V, Faroni J, et al. Multiple sclerosis in childhood: clinical features of 149 cases. Mult Scler. 1997;3:43-46.
9. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13:227-231.
10. Martyn CN, Cruddas M, Compston DA. Symptomatic Epstein-Barr virus infection and multiple sclerosis. J Neurol Neurosurg Psychiatry. 1993;56:167-168.
11. Poskanzer DC, Sever JL, Sheridan JL, Prenney LB Multiple sclerosis in the Orkney and Shetland Islands, IV: viral antibody titres and viral infections. J Epidemiol Community Health. 1980;34:258-264.
12. Poskanzer DC, Sever JL, Terasaki PI, et al. Multiple sclerosis in the Orkney and Shetland Islands, V: the effect on viral titres of histocompatibility determinants. J Epidemiol Community Health. 1980;34:265-270
13. Marrie RA, Wolfson C, Sturkenboom MC, et al. Multiple sclerosis and antecedent infections: a case-control study. Neurology. 2000;54:2307-2310.
14. Haahr S, Munch M, Christensen T, Moller-Larsen A, Hvas J. Cluster of multiple sclerosis patients from Danish community. Lancet. 1997;349:923.
15. Bray PF, Luka J, Bray PF, Culp KW, Schlight JP. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology. 1992;42:1798-1804.
16. van Noort JM, Bajramovic JJ, Plomp AC, van Venrooij WJ. Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis. J Neuroimmunol. 2000;105:46-57.
17. Knox KK, Brewer JH, Henry JM, Harrington DJ, Carrigan DR. Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease. Clin Infect Dis. 2000;31:894-903.
18. Cuomo L, Angeloni A, Zompetta C, et al. Human herpesvirus 6 variant A, but not variant B, infects EBV-positive B lymphoid cells, activating the latent EBV genome through a BZLF-1-dependent mechanism. AIDS Res Hum Retroviruses. 1995;11:1241-1245.
19. Swanborg RH, Whittum-Hudson JA, Hudson AP. Infectious agents and multiple sclerosis - are Chlamydia pneumoniae and human herpes virus 6 involved? J Neuroimmunol. 2003;136:1-8.
20. Allen UD, Tellier R, Doyle J, et al. The utility of plasma polymerase chain reaction for human herpes virus-6 among pediatric bone marrow transplant recipients: results of a pilot study. Bone Marrow Transplant. 2001;28:473-477.
21. Granieri E, Casetta I. Selected reviews common childhood and adolescent infections and multiple sclerosis. Neurology. 1997;49:S42-S54.
22. Levin LI, Munger KL, Rubertone MV, et al. Multiple sclerosis and Epstein-Barr virus. JAMA. 2003;289:1533-1536.
23. Martin JR. Herpes simplex virus types 1 and 2 and multiple sclerosis. Lancet. 1981;2:777-781.
24. James JA, Kaufman KM, Farris AD, et al. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest. 1997;100:3019-3026.